首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Tetracycline-Resistant T-Mycoplasmas (Ureaplasma urealyticum) from Patients with a History of Reproductive Failure
【2h】

Tetracycline-Resistant T-Mycoplasmas (Ureaplasma urealyticum) from Patients with a History of Reproductive Failure

机译:有生殖衰竭史的患者对四环素具有抗性的支原体(解脲脲原体)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The susceptibilities of T-mycoplasmas (Ureaplasma urealyticum) to minocycline, demeclocycline, doxycycline, tetracycline, and erythromycin were determined by a direct tube dilution test. T-mycoplasma-positive urine sediments of 105 patients with a history of reproductive failure were used as inocula. Minocycline was found to be the most active of the group of antibiotics commonly used to eradicate T-mycoplasma infection. Based on the median initial minimum inhibitory concentration, minocycline was the lowest with 0.03 μg/ml, followed by demeclocycline and doxycycline with 0.125 μg/ml, tetracycline with 0.25 μg/ml, and erythromycin with 2.0 μg/ml. Six T-mycoplasma isolates which had been cloned three times were also tested for susceptibility to the same five antibiotics. The same susceptibility pattern was found. Strains resistant to high concentrations of all antibiotics occurred. Strong positive correlation was seen in 21 patients between in vitro highly resistant strains and positive posttreatment cultures. These results indicate that empirical treatment of genital mycoplasma infections is not justified. Cultures should be taken pretreatment, susceptibility testing performed prior to treatment, and follow-up cultures done posttreatment.
机译:通过直接管稀释试验确定了T-支原体(解脲脲原体)对米诺环素,地美环素,强力霉素,四环素和红霉素的敏感性。 105例有生殖衰竭史的T支原体阳性尿沉渣被用作接种物。人们发现,米诺环素是通常用于根除T型支原体感染的最活跃的一组抗生素。根据中位数初始最小抑菌浓度,米诺环素最低,为0.03μg/ ml,其次是地美环素和强力霉素(0.125μg/ ml),四环素(0.25μg/ ml),红霉素(2.0μg/ ml)。还测试了已克隆了3次的6种T支原体分离株对相同5种抗生素的敏感性。发现了相同的敏感性模式。发生了对所有抗生素高浓度耐药的菌株。在21例体外高耐药菌株与阳性后培养之间观察到强正相关。这些结果表明,经验性治疗生殖道支原体感染是不合理的。应对培养物进行预处理,在治疗前进行药敏试验,并在治疗后进行后续培养。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号